Advances in the CDI Treatment Landscape

Experts discuss new and emerging treatments the management of CDI, highlighting the phase 3 trials for SER 109.

Related Videos
Glenn S. Tillotson, PhD: Treating Immunocompromised Patients With RBX2660
Adam Faye, MD: Treating the Older Population With IBD
Related Content
© 2023 MJH Life Sciences

All rights reserved.